| P/E (FY) | — | Sales (TTM) | $82.1M |
| Earnings (TTM) | $8.1M | ROE | −42.13% |
| Net Margin | −81.74% | ROIC | −43.89% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 13.67% |
Simulations Plus develops drug discovery and development software for modeling, simulation, and prediction of molecular properties using artificial intelligence and machine learning worldwide, operating through Software and Services segments. Its products include GastroPlus, which predicts absorption and pharmacokinetics; DDDPlus and MembranePlus; mechanistic modeling tools such as DILIsym and NAFLDsym; the ADMET Predictor; and MedChem Designer.
| Market Cap | $370.7M | Trading Days | 5292 |
| 52W High | 21.01 |
| 52W Low | 11.09 |
| % Off High | −12.76% |
| YTD | 0.55% | 1Y | 34.38% |
| 3Y | −62.62% | 5Y | −60.49% |
| 10Y | 148.29% | Since incept. (ann.) | 16.38% |
Software 58% · Services 42%
| Ann. Volatility (1Y) | 50.10% | Ann. Volatility (3Y) | 54.92% |
| Sharpe (1Y) | 0.85 | Sharpe (3Y) | −0.33 |
| Max Drawdown (1Y) | −45.49% | Max Drawdown (3Y) | −77.81% |
| Beta (3Y, vs SPY) | 1.23 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| RBBN | Ribbon Communications Inc. | $361.1M | 9.3 |
| TLS | TELOS CORP | $344.2M | — |
| MRLN | Merlin, Inc. | $343.6M | — |
| UIS | UNISYS CORP | $250.1M | — |
| OSPN | OneSpan Inc. | $572.4M | 8.2 |
| ASUR | ASURE SOFTWARE INC | $236.6M | — |
| SMRT | SmartRent, Inc. | $192.8M | — |
| KDK | Kodiak AI, Inc. | $755.6M | — |
| WYY | WIDEPOINT CORP | $99.6M | — |
| CSPI | CSP INC /MA/ | $81.9M | — |
| BNAI | Brand Engagement Network Inc. | $80.0M | — |
| ODYS | Odysight.ai Inc. |
| $73.0M |
| — |
